FDA calls idea of half-dosing Moderna COVID-19 vaccines ‘premature’

The FDA declined to immediately approve administering Moderna coronavirus vaccines in half-doses in a bid to distribute the shot wider across the U.S. population, saying the move would be “premature” and doesn’t have the full weight of science behind it.

Return to normalcy requires vaccines, masks, distance

Experts told FOX 5 NY that people who get the vaccine are encouraged to still wear masks and limit contact. Herd immunity will likely be achieved if 80% to 85% of Americans are vaccinated.